Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GK.8.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GK.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XENChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XCVNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.31.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.50NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.78NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.43NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HR.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HK.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HS.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HH.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HU.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HV.1.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.11NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.1.27NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.7.22NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GP.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.3.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBVNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.397NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.277NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.294NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.81NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HV.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.2.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KK.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.3.17NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FG.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GN.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FY.1.2.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.413NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FY.5.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JD.1.2.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.268NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.409NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FG.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KV.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GK.1.6NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.2.31NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.587NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.232NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.2.60NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CD.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CM.4.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.1.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
DE.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-17507.2China
BQ.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.333NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used